-
Kiss takes reins as Wallabies face Japan
-
Oil extends gains and stocks fall on fresh Hormuz worries
-
North Korea touts dog soup and other home-cooked recipes to beat the heat
-
Venezuela's political transition talks wrap first day in Caracas
-
UK observatory nervously watches growing space junk threat
-
South Africa coach Erasmus wary of struggling Argentina
-
Meta ordered to pay US state $567 mn to abate 'public nuisance' and child harm
-
Actress, engineer, jihadist's widow among Syria's new women MPs
-
Houthi missile attacks kill 58 Saudi-backed Yemeni govt forces: source
-
Battling Norrie survives match point to oust de Minaur
-
No.1 Sabalenka and Pegula advance at Toronto
-
US firm takes on backyard mosquitoes -- with 600,000 mosquitoes
-
China missile test top of agenda as Pacific diplomats meet in Fiji
-
Thousands protest private property legislation in Argentina
-
Most UK teens to opt out of planned social media curfew: poll
-
Battling Norrie survives match point to oust de Minaur at Montreal
-
Venezuela's political transition talks launch in Caracas
-
Venezuela's political transition talks start: AFP
-
2 killed, 13 wounded in bus blast near Syrian capital: state media
-
Real Madrid extend Vinicius deal, sign Diomande in title bid boost
-
All Blacks skipper Taylor cautiously recovering from calf strain
-
PSG sign France midfielder Akliouche from Monaco
-
UN chief denounces Russia, Ukraine for civilian deaths
-
CONMEBOL 'expresses concern regarding repeated unilateral actions' by FIFA
-
UEFA turn up the pressure on Infantino and repeat boycott threat
-
Warren coy over whether Fury-Joshua will be in UK or US
-
Rodri approves Barcelona transfer talks with Man City: Barca source to AFP
-
Taiwan blocks key bridge in drill for potential Chinese invasion
-
Venezuela unable to tally missing from cataclysmic quakes
-
Migrant children risk abuse on streets of Ceuta, aid groups warn
-
Le Court sprints to stage six Tour de France Femmes win
-
Oil price shoots up as stocks tread water
-
Doping body says Parker's positive cocaine test caused by nutritionist
-
British Grand Prix stays on MotoGP calendar until 2028
-
UEFA says boycott of World Cups stands despite FIFA backdown on private investment
-
Britain's EasyJet flies into US hands as takeover confirmed
-
Rheinmetall sales keep surging despite cancelled naval frigate project
-
Real Madrid sign Ivory Coast winger Yan Diomande
-
Pogacar teammate Del Toro gets new UAE deal after Tour podium
-
How online disinformation fuelled Ceuta migrant surge
-
Stocks tread water with earnings, tech in focus
-
Inevitable AI Group Raises $6M From Aleph to Launch AI-Native SaaS Companies
-
Forex Expo Dubai Announces Opportunity to Win Up to 150 Grams of Gold This September 2026
-
Suspected Ebola death on boat heading for DR Congo capital
-
Forlan named new Uruguay head coach
-
England selector North not 'hung up' on Stokes absence
-
UEFA chief Ceferin: 'Underdog' leader taking fight to FIFA's Infantino
-
UK Anti-Doping confirm former world champ Parker's ban lifted
-
Salah completes move to Turkey's Trabzonspor
-
French winemakers dread 'smoky taste' after wildfires
Global Covid cases up 80% as new subvariant rises
The number of new Covid-19 cases reported worldwide rose by 80 percent in the last month, the World Health Organization said on Friday, days after designating a new "variant of interest".
The WHO declared in May that Covid is no longer a global health emergency, but has warned that the virus will continue to circulate and mutate, causing occasional spikes in infections, hospitalisations and deaths.
In its weekly update, the UN agency said that nations reported nearly 1.5 million new cases from July 10 to August 6, an 80 percent increase compared to the previous 28 days.
However the number of deaths fell by 57 percent to 2,500.
The WHO warned that the reported number of cases and deaths do not reflect the true numbers, in part because countries carry out far less testing and monitoring than during earlier stages of the pandemic.
Many of the new cases came in the Western Pacific region, which saw infections jump by 137 percent, the WHO said.
Several countries in the Northern Hemisphere, including the United States, United Kingdom, France and Japan have seen a summer uptick in cases in recent weeks.
Experts have suggested that summer gatherings and travel, declining immunity and a new subvariant may have all played a role in the increase.
On Wednesday, the WHO designated the Omicron subvariant EG.5 as a "variant of interest" following a steady rise in its prevalence.
More than 17 percent of all reported cases were EG.5 in mid-July, up from 7.6 percent a month before, according to the WHO.
- Subvariant poses 'low' risk -
EG.5, which has been unofficially nicknamed "Eris" online, is considered to be a descendant of the XBB lineage of the virus.
It seems to be more transmissible than other circulating variants, likely due to a mutation in its spike protein, and the WHO said it has shown an ability to evade immunity.
But there is no sign that EG.5 causes more severe Covid symptoms and it poses a "low" risk to global public health, the WHO said, comparing its threat to other recent Omicron subvariants.
Nonetheless, WHO chief Tedros Adhanom Ghebreyesus warned that "the risk remains of a more dangerous variant emerging that could cause a sudden increase in cases and deaths".
France's Health Minister Aurelien Rousseau called for vigilance, while emphasising that Covid numbers remain at low levels.
"We will have to live with the resurgence of this virus for several seasons to come," he said in a statement sent to AFP.
Antoine Flahault, director of the Institute of Global Health at the University of Geneva, told AFP that the true Covid situation remained unclear "just about everywhere in the world".
"Health authorities urgently need to reinstate a reliable Covid health monitoring system," he said, calling for wastewater to be analysed to detect virus trends.
While the impact of Covid has been greatly diminished due to high levels immunity from either vaccination or prior infection, the virus still poses a threat -- including long Covid, for which symptoms can last for months or years.
The WHO has urged countries to ramp up vaccination efforts.
Pharmaceutical firms Pfizer/BioNTech, Moderna and Novavax are all working on updating their Covid vaccines to target XBB subvariants.
J.V.Jacinto--PC